CytomX Therapeutics' Series B - III Round

CytomX Therapeutics raised a round of funding on April 29, 2014.

CytomX Therapeutics is a biotechnology company developing Probody therapeutics for the treatment of cancer. Probodies are masked antibodies that remain inert in healthy tissue but are activated specif…

Articles about CytomX Therapeutics' Series B - III Round: